We are very honored to receive Swiss Cancer Research Foundation & Swiss Cancer League (Krebsforschung Schweiz & Krebsliga) grant fund for conducting “First in human clinical trial with armoured anti-EGFRvIII-SGRP CARs against glioblastoma” project at the University Hospital of Basel. June 2023 – June 2026
You may also like
The vertebrate adaptive immune systems (Agnatha and Gnathostomata) use sets of T and B lymphocyte lineages that somaticallygenerate highly diverse repertoires of […]
Glioblastoma (GBM) harbors a highly immunosuppressive tumor microenvironment (TME) which influences glioma growth. Major efforts have been undertaken to describe the TME […]
Nazanin Tatari is this year’s recipient of University and University Hospital of Basel Research Fund for Excellent Junior Researchers (Promoting Young Academic Talent […]
Deniz Kaymak is this year’s recipient of prestigious Swiss National Science Foundation MD-PhD award in Hutter’s lab (June 2022). Way to go, Deniz!